Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
PAIN AID ESF- (Acetaminopehn USP 250mg Recalled by ULTRAtab Laboratories, Inc. Due to CGMP Deviations: failed stability results, inadequate laboratory investigations,
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact ULTRAtab Laboratories, Inc. directly.
Affected Products
PAIN AID ESF- (Acetaminopehn USP 250mg, Asprin USP 250mg Caffeine 65mg) coated, bulk OTC tablets packaged in corrugated boxes lined with 2 polyethylene bags 100 lb, ULTRAtab Laboratories, Inc. NDC# 62959-560-00, Product Code M560L
Quantity: 14 bulk lots (approximately 1,987,951 tablets each)
Why Was This Recalled?
CGMP Deviations: failed stability results, inadequate laboratory investigations,
Where Was This Sold?
Product was distributed to one customer who may have further distributed the product.
About ULTRAtab Laboratories, Inc.
ULTRAtab Laboratories, Inc. has 43 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report